With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
The approval of Pfizer’s maraviroc was dealt a blow Wednesday as the drug’s maker received an approvable letter from the FDA requesting additional information on the investigational HIV compound. The ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Maraviroc proved noninferior to efavirenz among treatment-naive patients but is still unlikely to see much use in this population. The FDA recently approved the CCR5 inhibitor maraviroc for ...
November 24, 2009 — The US Food and Drug Administration (FDA) has approved an expanded indication for maraviroc (Selzentry tablets, ViiV Healthcare) for combination antiretroviral treatment of ...
The FDA has granted approval to Pfizer’s maraviroc HIV treatment, the drugmaker said today. Maraviroc, to be marketed under the brand name Selzentry, is expected to be available in the US by the ...
Please provide your email address to receive an email when new articles are posted on . Adding maraviroc to a standard three-drug antiretroviral therapy regimen in patients with advanced HIV did not ...
Washington –According to the recent communiqué from US drug reviewers, the experimental AIDS drug from Pfizer Inc. promises to contain the HIV virus when used in combination with popular drugs. The ...
Review the side-effects of Maraviroc as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
The two-drug regimen of maraviroc + darunavir/ritonavir proved inferior to the three-drug regimen of tenofovir/emtricitabine + darunavir/ritonavir in antiretroviral-naive adults with HIV-1 infection, ...
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken ...
The FDA approved maraviroc in 150 mg and 300 mg tablets as the newest treatment for adults with HIV, last month. Maraviroc is the first CCR-5 co-receptor antagonist, representing the first therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results